Lv1
20 积分 2021-08-02 加入
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
3天前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
9天前
已完结
[HER2 status in gastric adenocarcinoma of Chinese: a multicenter study of 40 842 patients]
10天前
已完结
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
10天前
已完结
Cholangiocarcinoma
1个月前
已完结
Gastric cancer
1个月前
已关闭
Distinct clinicopathologic features and efficacy of adjuvant therapy in intraductal papillary mucinous carcinoma compared with conventional pancreatic ductal adenocarcinoma
1个月前
已关闭
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial
1个月前
已完结
HER3 upregulation reduces DS-8201 sensitivity in HER2-positive tumor cells by ATR/CHK1/FoxO1 signaling cascade
1个月前
已完结
Anbenitamab in previously treated HER2-positive gastric cancer (KC-WISE): pre specified interim analysis of a randomized, phase III clinical trial
2个月前
已完结
皖公网安备34019202002308